This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Villamil, M. F. Articles by Taquini, A. C. Search for Related Content PubMed PubMed Citation Articles by Villamil, M. F. Articles by Taquini, A. C.

Hypertension, Vol 4, 620-624, Copyright © 1982 by American Heart Association

ARTICLES

Role of extracellular volume expansion in the development of DOC-salt hypertension in the rat

MF Villamil, C Amorena, J Ponce-Hornos, A Muller and AC Taquini

Changes in inulin space, plasma and blood volume, exchangeable and "noninulin" sodium were studied during the prehypertensive, early and late hypertensive stages of deoxycorticosterone (DOC)-salt administration in the rat. The effect of an acute water load in previously nephrectomized animals was also studied. Hypertension developed after 1 to 2 weeks of the DOC-salt regimen and was always preceded by enlargement of the inulin space and increased plasma and blood volume. Expansion of extracellular fluids receded when blood pressure started to rise but reappeared after 4 to 6 weeks of treatment. Plasma sodium was high only in the hypertensive groups. An acute water load increased blood pressure of normal rats and decreased blood pressure of DOC-salt early hypertensive rats. These findings suggest that extracellular volume expansion inhibits a vasopressor mechanism that involves vasopressin and could be stimulated by hypernatremia.

This article has been cited by other articles:

				M. P. Blaustein, J. Zhang, L. Chen, and B. P. Hamilton How does salt retention raise blood pressure? Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R514 - R523. [Abstract] [Full Text] [PDF]

				D. M. Roesch, R. E. Blackburn-Munro, and J. G. Verbalis Mineralocorticoid treatment attenuates activation of oxytocinergic and vasopressinergic neurons by icv ANG II Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2001; 280(6): R1853 - R1864. [Abstract] [Full Text] [PDF]